Creative Biolabs Advances Antibody Engineering with Innovative Glycosylation Technology
Creative Biolabs has developed a sophisticated analytical platform for monoclonal antibody glycan profiling, enhancing therapeutic antibody effectiveness through precise Fc region modifications. These technological improvements could significantly impact biopharmaceutical drug development.
